NCT03001245

Brief Summary

The aim of this cluster randomized trial is to investigate whether the brief, 1+6 session psychosocial intervention, Interpersonal Counseling (IPC) is more effective than standard professional treatment (ST) in the treatment of mild or moderate depression among 12 to 17-year-old adolescents in services provided by school health care and counseling professionals (school nurses, school psychologists and school social workers). The clients are identified from the pool of adolescents routinely seen in school health care and counseling services. A total of 54 school nurses, social workers, and psychologists from all public secondary schools in the standard education system of City of Espoo, Finland will be trained in IPC in a three-day workshop in two waves. Each school (plus the one primary care level health care unit for adolescents in Espoo) is represented by 1-3 trial IPC counselors. In the first wave the schools are cluster randomized to provide either A) 1+6 sessions of IPC, or B) 1+6 sessions of standard treatment (ST), which consists of psychosocial work as guided by the workers' own standard professional principles and methods. The workers randomized to deliver IPC get the IPC training immediately. In the second wave those who delivered ST in the first wave will be trained in IPC. The data for this trial will be collected from the first wave. The data collection period is one school year plus follow-up of clients after 3 and 6 months. The clients are adolescents who have either self-referred themselves, are referred by other school personnel, or by parents to the services offered in the school due to emotional symptoms in the school year 2016 -2017 in the participating schools. They are screened with the BDI at the initial visit to identify depressive symptoms. A diagnostic interview will be administered to those exceeding a clinical cutoff. Main inclusion criterion is DSM-5 depressive disorder of either mild or moderate severity. Those with current harmful alcohol use, acute suicidal ideation or behavior, severe depression or anxiety disorder, psychotic symptoms or very low global level of functioning are excluded and offered other treatment. The clients will complete self-report questionnaires (BDI) as outcome measures. Their level of depression symptoms will also be assessed with ADRS scale and their level of global psychosocial functioning with the CGAS by the project IPC counselors / ST providers. Moreover, the clients will complete the Young Person's Clinical Outcomes for Routine Evaluation (YP-CORE) as a measure of global symptomatology after each session. A follow-up interview at 3 months and 6 months after treatment termination will be arranged. The K-SADS-PL will be used for diagnostic evaluation, the ADRS and the C-GAS to assess level of depressive symptoms and global functioning, and the adolescent completes both the BDI and YP-CORE as self-reports of symptomatology.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 22, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

December 22, 2016

Status Verified

December 1, 2016

Enrollment Period

1.2 years

First QC Date

December 20, 2016

Last Update Submit

December 20, 2016

Conditions

Keywords

adolescentsdepressionpsychotherapyinterpersonal therapy

Outcome Measures

Primary Outcomes (4)

  • Change from Baseline in Adolescent Depression Rating Scale after six scheduled treatment sessions

    6 weeks

  • Change from Baseline in Children's Global Assessment of Functioning after six scheduled treatment sessions

    6 weeks

  • Change from Baseline in Beck Depression Inventory after six scheduled treatment sessions

    6 weeks

  • Change from Baseline in Young Person's Clinical Outcomes for Routine Evaluation after six scheduled treatment sessions

    one, two, three, four, five, and six weeks

Secondary Outcomes (10)

  • Change from Baseline in diagnostic status regarding depressive disorder assessed with Kiddie-Sads-Present and Lifetime Version 3 months after treatment termination

    3 months after treatment termination

  • Change from Baseline in diagnostic status regarding depressive disorder assessed with Kiddie-Sads-Present and Lifetime Version 6 months after treatment termination

    6 months after treatment termination

  • Change from Baseline in Adolescent Depression Rating Scale 3 months after treatment termination

    3 months after treatment termination

  • Change from Baseline in Adolescent Depression Rating Scale 6 months after treatment termination

    6 months after treatment termination

  • Change from Baseline in Beck Depression Inventory 3 months after treatment termination

    3 months after treatment termination

  • +5 more secondary outcomes

Study Arms (2)

IPC

EXPERIMENTAL

Interpersonal Counseling

Behavioral: Interpersonal Counseling

ST

ACTIVE COMPARATOR

Standard treatment

Behavioral: Standard treatment

Interventions

Interpersonal Counseling 1+6 sessions

IPC

Psychosocial treatment 1+6 sessions guided by the professional's standard professional principles and routinely available methods

ST

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical diagnosis of DSM-5 Depressive Disorder (severity mild or moderate)

You may not qualify if:

  • current harmful alcohol use
  • acute suicidal ideation or behavior
  • severe depressive disorder
  • severe anxiety disorder
  • psychotic symptoms
  • very low global level of functioning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Adolescent Psychiatry, Helsinki University Central Hospital

Helsinki, P. O.Box 590, FI-00029, Finland

RECRUITING

MeSH Terms

Conditions

Depressive DisorderDepression

Condition Hierarchy (Ancestors)

Mood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Klaus Y Ranta, M.D., Ph.D.

    Hospital District of Helsinki and Uusimaa, Helsinki University Central Hospital

    STUDY CHAIR
  • Mauri Marttunen, M.D., Ph.D.

    University of Helsinki, Department of Adolesecent Psychiatry

    STUDY DIRECTOR

Central Study Contacts

Klaus Y Ranta, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department, Department of Adolescent Psychiatry, Helsinki University Central Hospital

Study Record Dates

First Submitted

December 20, 2016

First Posted

December 22, 2016

Study Start

September 1, 2016

Primary Completion

December 1, 2017

Study Completion

December 1, 2018

Last Updated

December 22, 2016

Record last verified: 2016-12

Locations